Axcelis Technologies, Inc. (ACLS) Stock Analysis
Breakout setup
Technology · Semiconductor Equipment & Materials
Hold if already holding. Not a fresh buy at $180.01, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%).
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current... Read more
Hold if already holding. Not a fresh buy at $180.01, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%). Chart setup: Golden cross, above all MAs, RSI 62, MACD bullish. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 5.1/10, high confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
About Axcelis Technologies, Inc.
About Axcelis Technologies, Inc.
Axcelis Technologies manufactures ion implant systems for semiconductor chip manufacturers, with international sales representing 83.7% of total revenue in 2025 and Asia-based system shipments accounting for 76.0% of total system revenue the same year. The top ten customers comprised 55.2% of net sales in 2025, and individual system prices range from approximately $2.6 million to $12.0 million. A recurring aftermarket stream of parts, consumables, upgrades, and service contracts supplements new system sales.
Axcelis earns revenue through two primary streams: new ion implant system sales to semiconductor chip manufacturers and an aftermarket business comprising parts, consumables, upgrades, service contracts, and time-and-materials billings. The aftermarket historically provides a significant portion of product revenue and all service revenue, offering partial insulation from cyclical swings in new equipment orders. System purchases depend entirely on semiconductor manufacturers' capital expenditure decisions, creating lumpy quarterly revenue where individual systems can materially shift a period's results. Component manufacturing relies on a limited group of outside vendors who produce subassemblies through complex processes with long lead times, limiting the company's ability to substitute on short notice. Competition includes one company with substantially greater financial and engineering resources, plus smaller non-U.S. rivals including Advanced Ion Beam Technology, Inc., Nissin Ion Equipment Co., Ltd., and Sumitomo Heavy Industries Ion Technology Co., Ltd., all of which may benefit from U.S.-China trade restrictions pushing Chinese customers toward non-American vendors.
Show full overview
China-related export control risk represents the most identifiable regulatory exposure: SMIC was placed on the U.S. Entity List in 2020, requiring Axcelis to obtain export licenses for shipments to SMIC fabs, and the October 2022 BIS framework prohibits all semiconductor equipment exports to Chinese customers producing or developing advanced logic, DRAM, and NAND chips meeting specific parameters. The 10-K states that "continuing revenue from Chinese customers is at higher risk than continuing revenue from customers in other international locations." Two domestic Chinese companies — Kingstone Semiconductor and CETC Electronics Equipment Group Co., Ltd. — continue developing local ion implanters, raising the prospect of permanent Chinese market share erosion regardless of broader trade policy shifts. In March 2026, the company disclosed via Form 8-K the departure of CFO James Coogan, with an internal appointment of an Interim CFO underway.
See also: Technology · Semiconductor Equipment & Materials
From Axcelis Technologies, Inc.'s most recent 10-K filing, extracted June 9, 2026.
Recent developments
updated 2026-06-14Recent Developments — Axcelis Technologies, Inc.
Latest news
- NEWS Carolina Panthers RB Jonathon Brooks' faith has helped him through father's death, 2 torn ACLs - ABC11 Raleigh-Durham — ABC11 Raleigh-Durham neutral
- NEWS Why Axcelis Technologies Stock Is Sinking Today - TipRanks — TipRanks negative
- NEWS Female Athletes’ Physical and Mental Struggle to Recover From Torn ACLs - Education Week — Education Week neutral
- NEWS ACLS Welcomes Five Scholarly Associations to Its Federation of Member Societies - PR Newswire — PR Newswire positive
- NEWS Axcelis Technologies (ACLS) exceeds market returns: Some facts to consider - MSN — MSN positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHGeographicinternational sales84%10-K Item 1A: 'International sales...accounted for 83.7% of total revenue in 2025'
- HIGHGeographicAsia76%10-K Item 1A: 'Ion implanter system shipments to customers in Asia represented 76.0% of total system revenue in 2025'
- HIGHCustomertop ten customers55%10-K Item 1A: 'our top ten customers accounted for 55.2% of our net sales'
- MEDIUMSupplierlimited group of suppliers10-K Item 1A: 'We obtain many of these components and sub-assemblies from a limited group of suppliers'
Material Events(8-K, last 90d)
- 2026-03-12Item 5.02MEDIUMCFO James Coogan notified Axcelis of resignation effective April 24, 2026; no disagreement cited. Board appointed David Ryzhik (SVP of Investor Relations and Corporate Strategy since July 2024) as Interim CFO effective March 12, 2026.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $180.01, but acceptable to hold if already in. Reasons: Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%). Chart setup: Golden cross, above all MAs, RSI 62, MACD bullish. Multiple concerning factors. Consider reducing position. | News modifier +2 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Target $179.95 (-0.0%), stop $167.51 (−7.5%), A.R:R -1.6:1. Score 5.1/10, high confidence.
Take-profit target: $179.95 (-0.1% upside). Target $179.95 (-0.0%), stop $167.51 (−7.5%), A.R:R -1.6:1. Stop-loss: $167.51.
Concentration risk — Geographic: international sales (83.7%); Concentration risk — Geographic: Asia (76.0%); Analyst target reached - limited upside remaining.
Axcelis Technologies, Inc. trades at a P/E of 55.9 (forward 38.9). TrendMatrix value score: 3.8/10. Verdict: Hold.
12 analysts cover ACLS with a consensus score of 3.7/5. Average price target: $161.
What does Axcelis Technologies, Inc. do?Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in...
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current implanters for various application requirements. It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor chip manufacturers through its direct sales force. Axcelis Technologies, Inc. was founded in 1978 and is headquartered in Beverly, Massachusetts.